跳至主要内容
临床试验/ACTRN12619000986178
ACTRN12619000986178已完成未知

The Assessment of Fluoxetine in Stroke Recovery Imaging and Blood Biomarkers Sub - Study AFFINITY BM

Sir Charles Gairdner Hospital0 个研究点目标入组 241 人开始时间: 2019年7月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
241

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants may partake of either one or both of the sub studies
  • Blood Biomarkers sub study:
  • Participants randomised and participating in the AFFINITY Trial
  • MRI neuroimaging sub study:
  • Participants randomised and participating in the AFFINITY Trial
  • Brain imaging consistent with an ischaemic stroke of either hemisphere
  • Brain imaging conducted within 21 days of qualifying stroke event

排除标准

  • MRI neuroimaging sub study:
  • Brain imaging consistent with haemorrhagic (intracerebral and / or subarachnoid) stroke
  • Contra-indication to having a MRI e.g. implanted pacemaker or severe claustrophobia (these people can still participate in the blood biomarker sub-study)
  • Unable to undergo follow up MRI at six months

研究者

相似试验